Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 12 | 2016 | 223 | 1.800 |
Why?
|
| Choroid | 9 | 2014 | 26 | 1.740 |
Why?
|
| Wet Macular Degeneration | 4 | 2014 | 26 | 0.690 |
Why?
|
| Retinal Diseases | 2 | 2016 | 33 | 0.560 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2012 | 14 | 0.550 |
Why?
|
| Vitreoretinal Surgery | 1 | 2016 | 4 | 0.490 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2016 | 9 | 0.490 |
Why?
|
| Vitreous Body | 1 | 2016 | 31 | 0.480 |
Why?
|
| Eye Diseases | 1 | 2016 | 36 | 0.480 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 58 | 0.470 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2014 | 77 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 213 | 0.360 |
Why?
|
| Diabetic Retinopathy | 3 | 2016 | 53 | 0.320 |
Why?
|
| Retinal Perforations | 2 | 2016 | 8 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2015 | 2576 | 0.170 |
Why?
|
| Aged | 9 | 2016 | 14443 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2015 | 5462 | 0.150 |
Why?
|
| Visual Acuity | 3 | 2013 | 125 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2016 | 6660 | 0.140 |
Why?
|
| Male | 10 | 2016 | 29907 | 0.130 |
Why?
|
| Middle Aged | 8 | 2016 | 17610 | 0.130 |
Why?
|
| Organ Size | 2 | 2014 | 172 | 0.130 |
Why?
|
| Female | 10 | 2016 | 32890 | 0.120 |
Why?
|
| Epiretinal Membrane | 1 | 2016 | 2 | 0.120 |
Why?
|
| Vitreous Hemorrhage | 1 | 2016 | 3 | 0.120 |
Why?
|
| Intraoperative Period | 1 | 2016 | 33 | 0.120 |
Why?
|
| Retinal Neoplasms | 1 | 2016 | 18 | 0.120 |
Why?
|
| Retinoblastoma | 1 | 2016 | 28 | 0.120 |
Why?
|
| Retinal Vessels | 1 | 2015 | 18 | 0.120 |
Why?
|
| Young Adult | 4 | 2015 | 4695 | 0.120 |
Why?
|
| Retinal Detachment | 1 | 2016 | 18 | 0.120 |
Why?
|
| Fluorescein Angiography | 1 | 2015 | 58 | 0.120 |
Why?
|
| Fovea Centralis | 2 | 2014 | 17 | 0.120 |
Why?
|
| Reference Values | 2 | 2011 | 335 | 0.110 |
Why?
|
| Geographic Atrophy | 1 | 2014 | 20 | 0.100 |
Why?
|
| Ranibizumab | 1 | 2013 | 20 | 0.100 |
Why?
|
| Retreatment | 1 | 2013 | 47 | 0.100 |
Why?
|
| Retinitis Pigmentosa | 1 | 2013 | 27 | 0.100 |
Why?
|
| Intravitreal Injections | 1 | 2013 | 49 | 0.100 |
Why?
|
| Bevacizumab | 1 | 2013 | 59 | 0.100 |
Why?
|
| Choroid Diseases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Humans | 12 | 2016 | 63464 | 0.090 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2011 | 8 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 696 | 0.090 |
Why?
|
| Observer Variation | 1 | 2011 | 214 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2013 | 236 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2462 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 621 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2016 | 1998 | 0.080 |
Why?
|
| Adult | 5 | 2015 | 16829 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 1653 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1094 | 0.070 |
Why?
|
| Microvessels | 1 | 2015 | 19 | 0.030 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2014 | 35 | 0.030 |
Why?
|
| Macular Edema | 1 | 2012 | 24 | 0.020 |
Why?
|
| Optic Disk | 1 | 2011 | 27 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2011 | 33 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 609 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1122 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2081 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 3294 | 0.020 |
Why?
|